Does controlled ovarian hyperstimulation in women with a history of borderline tumor influence recurrence rate?

Han Gao, Ning Wang(Tianjin University), Heng Wei(First Hospital of China Medical University), Wei Wei(Zhujiang Hospital), Yibing Li(Dalian Medical University)

Archives of Gynecology and Obstetrics

September 26, 2023

10.1007/s00404-023-07103-8

Cited by 4

Related Papers

Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion

|JAMA Oncology|2019|559

Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial

|Journal of Clinical Oncology|2020|217

Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma

|Therapeutic Advances in Medical Oncology|2021|216

Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety

|癌症：英文版|2018|189

A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome

|European Journal of Endocrinology|2011|160